Ascendis Pharma A/S Basic Earnings Loss Per Share
Ascendis Pharma A/S (ASND) reported Basic Earnings Loss Per Share of -3.76 EUR/shares for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Income Statement › Earnings Per Share
ifrs-full:BasicEarningsLossPerShare · last filed 2026-02-11
- Ascendis Pharma A/S basic earnings loss per share for the quarter ending 2025-09-30 was -1.00 EUR/shares.
- Ascendis Pharma A/S basic earnings loss per share for the quarter ending 2025-06-30 was -0.64 EUR/shares.
- Ascendis Pharma A/S basic earnings loss per share for the quarter ending 2025-03-31 was -1.58 EUR/shares.
- Ascendis Pharma A/S basic earnings loss per share for the quarter ending 2024-09-30 was -1.72 EUR/shares.
| Period end | Basic Earnings Loss Per Share 3 month | Basic Earnings Loss Per Share 6 month | Basic Earnings Loss Per Share 9 month | Basic Earnings Loss Per Share 12 month |
|---|---|---|---|---|
| 2025-12-31 | -3.76 EUR/shares 20-F · filed 2026-02-11 | |||
| 2025-09-30 | -1.00 EUR/shares 6-K · filed 2025-11-12 | -3.22 EUR/shares 6-K · filed 2025-11-12 | ||
| 2025-06-30 | -0.64 EUR/shares 6-K · filed 2025-08-07 | -2.22 EUR/shares 6-K · filed 2025-08-07 | ||
| 2025-03-31 | -1.58 EUR/shares 6-K · filed 2025-05-01 | |||
| 2024-12-31 | -6.53 EUR/shares 20-F · filed 2026-02-11 | |||
| 2024-09-30 | -1.72 EUR/shares 6-K · filed 2025-11-12 | -5.93 EUR/shares 6-K · filed 2025-11-12 | ||
| 2024-06-30 | -1.91 EUR/shares 6-K · filed 2025-08-07 | -4.21 EUR/shares 6-K · filed 2025-08-07 | ||
| 2024-03-31 | -2.30 EUR/shares 6-K · filed 2025-05-01 | |||
| 2023-12-31 | -8.55 EUR/shares 20-F · filed 2026-02-11 | |||
| 2023-09-30 | -2.88 EUR/shares 6-K · filed 2024-11-14 | -7.02 EUR/shares 6-K · filed 2024-11-14 | ||
| 2023-06-30 | -2.16 EUR/shares 6-K · filed 2024-09-03 | -4.14 EUR/shares 6-K · filed 2024-09-03 | ||
| 2023-03-31 | -1.98 EUR/shares 6-K · filed 2024-05-02 | |||
| 2022-12-31 | -10.40 EUR/shares 20-F · filed 2025-02-12 | |||
| 2022-09-30 | -3.03 EUR/shares 6-K · filed 2023-11-07 | -6.70 EUR/shares 6-K · filed 2023-11-07 | ||
| 2022-06-30 | -1.46 EUR/shares 6-K · filed 2023-09-05 | -3.68 EUR/shares 6-K · filed 2023-09-05 | ||
| 2021-12-31 | -7.00 EUR/shares 20-F · filed 2024-02-07 | |||
| 2018-06-30 | -0.55 EUR/shares 6-K · filed 2018-08-29 | -1.60 EUR/shares 6-K · filed 2018-08-29 | ||
| 2017-12-31 | -3.68 EUR/shares 20-F · filed 2018-03-28 | |||
| 2017-06-30 | -0.94 EUR/shares 6-K · filed 2018-08-29 | -1.72 EUR/shares 6-K · filed 2018-08-29 | ||
| 2016-12-31 | -2.58 EUR/shares 20-F · filed 2018-03-28 | |||
| 2015-12-31 | -1.39 EUR/shares 20-F · filed 2018-03-28 |